Colloidal Gold · COVID-19
SARS-CoV-2 IgM/IgG Antibody Detection Kit (Colloidal Gold)
Designed for in vitro qualitative detection of SARS-CoV-2 IgM and IgG antibodies in human serum, plasma, venous blood, and fingertip blood samples. Suitable for assessing immune response from natural infection or vaccination.
- SKU Code
AENE-RT090- Approval
- On request
- Product Type
- Assay / Kit
- Status
- Available
Designed for in vitro qualitative detection of SARS-CoV-2 IgM and IgG antibodies in human serum, plasma, venous blood, and fingertip blood samples. Suitable for assessing immune response from natural infection or vaccination.
| Product type | Assay / Kit |
|---|---|
| Technology platform | Colloidal Gold |
| Application area | COVID-19 |
Certificate
CE
Epidemiology
Coronavirus Disease 2019 (COVID-19) is a form of pneumonia resulting from infection with the novel coronavirus Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). SARS-CoV-2 is a newly identified coronavirus belonging to the β genus, and humans are generally susceptible to it. The primary sources of infection are individuals with confirmed COVID-19 and asymptomatic carriers of SARS-CoV-2. According to current epidemiological data, the incubation period ranges from 1 to 14 days, most commonly 3 to 7 days. The predominant symptoms include fever, dry cough, and fatigue. Some patients may also experience nasal congestion, runny nose, sore throat, myalgia, and diarrhea.
| SKU code | AENE-RT090 |
|---|---|
| Target region | SARS-CoV-2 IgM/IgG Antibody |
| Storage temperature | 4℃-30℃ |
| Sample type | Human serum, plasma, venous blood and fingertip blood |
| Shelf life | 24 months |
| Auxiliary instruments | Not required |
| Extra Consumables | Not required |
| Detection time | 10-15 mins |
| Specificity | There is no cross-reaction with pathogens, such as Human coronavirus SARSr-CoV, MERSr-CoV, HCoV-OC43, HCoV-229E, HCoV-HKU1, HCOV-NL63, H1N1, novel influenza A (H1N1) influenza virus, seasonal H1N1 influenza virus, H3N2, H5N1, H7N9, influenza B virus Yamagata, Victoria, respiratory syncytial virus A and B, parainfluenza virus type 1,2,3, Rhinovirus A, B, C, adenovirus type 1,2,3,4,5,7,55. |
| Approval | On request |
|---|---|
| Documents | Datasheet, IFU, SDS, COA / conformance, origin, and export documents where available |
FAQ
What should be confirmed before quotation?
Sample context, collection method, and extraction workflow should be confirmed before final kit selection.
Which documents can be requested?
Datasheet, IFU, SDS, COA / conformance, origin, insurance, and export documents can be checked where available.
Can the format be adjusted for different workflows?
Liquid or lyophilized format options should be confirmed together with instrument compatibility and shipment requirements.
Related products
Inquiry
Send the essentials for a useful first reply.
Share the application, sample type, format, destination, and expected quantity so AeneBio can route AENE-RT090 to the right quote or sample discussion.